Immunoglobulin (Ig) molecules have two major functions: to serve as antigen receptors on the surface of B lymphocytes and to serve as effector antibodies after secretion from plasma cells. Recently it has been shown that the kL polypeptide chains of membrane-bound IgM have a hydrophobic domain at their COOH terminus that is missing from the JA chains of secreted IgM and that may play a role in the insertion of the A chains into the lipid bilayer of the cellular membrane (1) (2) (3) (4) (5) . B lymphocytes expressing IgM contain two different sized A mRNAs, one ofwhich codes for membrane-bound ,u chain and the other of which codes for secreted 1A chains (4) (5) (6) .
To determine whether there are differences between the a polypeptide chains of membrane-bound and secreted IgA, we examined the synthesis and processing of a chains in two murine cell lines: a B lymphoma, BFO (7) . The IgA-secreting hybridoma, ID150, was obtained by hybridization of 1. 29 cells with P3-NS. 1-Ag-8 myeloma cells (8, 9) . Both cell lines synthesize IgA and no other class of Ig. These cells were maintained in RPMI 1640 medium supplemented with 10% fetal calfserum, 2 mM glutamine, penicillin (100 unit/ml), and streptomycin (100 j.g/ml).
Cell Surface Labeling, Biosynthetic Labeling, and Immunoprecipitation. The cell surface was labeled either by lactoperoxidase (10) or with NaB3H4 and NaIO4 (11) , using 5 mCi of 125I or 0.5 mCi of NaB3H4, respectively, for 50 X 106 cells (1 Ci = 3.7 x 1010 becquerels).
Cells were biosynthetically labeled by incubation at 37C in a CO2 incubator in methionine-free RPMI 1640 medium containing 10% dialyzed fetal calfserum and [35S]methionine (New England Nuclear), or by incubation in glucose-free RPMI 1640 medium containing 10% dialyzed fetal calf serum and 3H-labeled sugar (New England Nuclear).
Lysis and immunoprecipitation by anti-a antiserum and Staphylococcus aureus Cowan I strain were performed according to Siden et aL (12) , using either rabbit anti-mouse a chain antiserum (Bionetics, Kensington MD) or affinity-purified goat anti-mouse a chain antibody made against IgA from MOPC 460 (gift from P. Kincade). The material immunoprecipitated by both antibodies was identical as analyzed by NaDodSO4/gel electrophoresis.
NaDodSO4/Polyacrylamide Gel Electrophoresis and TwoDimensional (2D) Gel Electrophoresis. Immunoprecipitates were analyzed by electrophoresis in 10% polyacrylamide slab gels containing NaDodSO4 (13) or by a combination of isoelectric focusing and electrophoresis on 2D gels (14) . '4C-Labeled proteins (Bethesda Research Laboratories, Rockville MD) were used as molecular weight markers. After electrophoresis, gels were treated with 2,5-diphenyloxazole (15), dried, and exposed to Kodak XR film at -800C.
Isolation of RNA, RNA Blotting, and In Vitro Translation. RNA was isolated from cytoplasmic fractions that were prepared from ID150 and from BFO.3 cells by lysing them in a Dounce homogenizer in 0.5% Nonidet P40/10 mM Tris HCl (pH 7.4)/ 140 mM NaCl/1.5 mM MgCl2, followed by centrifugation at 650 x g for 10 min to pellet the nuclei. The cellular homogenates appeared to contain intact nuclei and a small fraction of whole cells by examination in the light microscope. The cytoplasm was adjusted to 10 mM ribonucleoside-vanadyl complexes (16)/10 mM Na2EDTA (pH 7.0)/0.5% NaDodSO4. RNA was extracted with phenol/chloroform. Poly(A)+ RNA was isolated by two successive adsorptions to oligo(dT)-cellulose. To determine the size of the a chain RNAs, RNA was denatured with dimethyl sulfoxide and glyoxal, fractionated by electrophoresis on 1% agarose gels in 10 mM phosphate at pH 7.0 (17), and blotted (18) to diazophenyl-thioether paper, which was prepared according to B. Seed (see footnote 51 in ref. 18 ). The RNA blots were hybridized as described (19) Fig. 1A , lysates of BFO.3 cells contained two spots, a and a', a cluster of small spots, b, and (8, 22) .
IgA was immunoprecipitated from the medium in which the ID150 cells had been labeled and was analyzed on a 2D gel. In addition to the spots observed in the lysate of ID150 cells, a smear of spots extending from a' in the acidic direction and an acidic spot, d, with an apparent Mr of 23,000 were observed (Fig. 1C) . Spot d probably corresponds to the J chain, which is associated with secreted IgA and which migrates similarly to the immunoglobulin light chain on NaDodSO4/polyacrylamide gels (23, 24) . It was also detected in the lysates of ID150 cells upon longer exposure of the film (data not shown). Spot d was not detected in BFO.3 cells.
Identification of Membrane-Bound a Chains (am) by Cell Surface Labeling. To determine which spots represent am, the surface of BFO.3 cells was labeled by radioiodination to label the tyrosine residues (10), and with NaB3H4 and NaIO4 to label the sialic acid residues (11) (Fig. 1 D and E, respectively) . BFO.3 cells labeled by both methods showed only one a chain spot, which corresponded to spot c ofinternally labeled BFO.3 cells, indicating that the most acidic a chain (spot c) was am.
Lysates of biosynthetically labeled ID150 cells did not show any spot that corresponded to am (Fig. 1B) , and little or no am could be detected by radioiodination or by immunofluorescence (unpublished results). Therefore, it appears that spots a and a' may be intracellular precursors for secreted a chain (as) and that these a chains become more acidic shortly before or during secretion.
Pulse-Chase Labeling of BFO. (Fig. 2B) . As the duration of the chase increased, spot(s) b became progressively fainter (Fig. 2 C-F) , almost disappearing by 6 hr (Fig. 2E ). Spot(s) b could not be detected after a 24-hr chase (Fig. 2F) . Spot c was still quite dark at 6 hr, but very faint after a 24-hr chase. These results suggest that spot(s) b represents an intracellular precursor for am (spot c) and that these proteins are rapidly turned over and shed from the membrane. Spots a and a' persisted 24 hr after the chase (although they became less intense), indicating that spots a and a' are not precursors for spots b and c, and they have a very slow turnover in BFO. After the chase, cells were lysed, and IgA was immunoprecipitated with anti-a chain antiserum.
acidic during their maturation. To determine whether glycosylation is involved in the processing of the a chains, BFO.3 and ID150 cells were labeled for 6 hr with three different sugars, either with [3H]mannose to label the core sugars or with [3H]fucose or [3H]galactose to label the terminal sugars (25) . As shown in Fig. 3 , it appears that in both ID150 and BFO.3 cells mannose was mostly incorporated into the same spot (a) that was pulse-labeled by methionine. By contrast, fucose and particularly galactose were incorporated to a greater extent into the most acidic spots. Because the patterns obtained by labeling with fucose differed from those obtained by labeling with galactose (galactose being incorporated into the more acidic molecules), the heterogeneity ofthe pI and molecular weight ofthe a chains may reflect the kinds and amounts of added sugars. mRNA for a Chains ofBFO.3 and ID150 Cells. Biosynthetic labeling experiments suggest that there are two distinct precursors for am and as. To provide further evidence for the existence of two different a polypeptides, we attempted to determine whether these cells contained more than one a chain mRNA. Cytoplasmic RNA from BFO.3 and ID150 cells was analyzed by gel electrophoresis, blotting to diazotized paper, and hybridization with a cloned cDNA, pa(J558) 3, coding for the a constant region (20) . Three species ofpoly(A)+ RNAs, 1.7, 2.1, and 3.1 kilobases (kb) in length, were detected in BFO.3 cells (Fig. 4) . Poly(A)+ RNA from ID150 cells also contained these same species, although the amount ofthe 1.7-kb RNA was much greater in ID150 than in BFO.3 cells. (In Fig. 4 (Fig. 5, lane e) . By contrast, one a polypeptide chain (Mr 59,000) was the predominant translation product o6fRNA from IDl50 cells (Fig. 5, lane f) , although a very faint larger a chain (Mr 62,000) was detected when the gel was exposed to film five times longer (lane f'). Because ID150 cells synthesize predominantly secreted IgA, it appears likely that the Mr 59,000 chain is the polypeptide precursor for a., and the Mr 62,000 polypeptide is the precursor for am.
The sizes of the a chains synthesized in vitro were compared with the sizes of a chains synthesized in vivo in the presence and absence oftunicamycin (Fig. 5, lanes a-d, a') . Tunicamycin inhibits N-linked glycosylation (26, 27) . The a chains synthesized in vitro were smaller than the a chains synthesized in vivo in the absence of tunicamycin (BFO.3, lane b; ID150, lane d) but larger than the a chains synthesized in tunicamycin-treated cells (BFO.3, lanes a, a'; ID150, lane c) , probably because the a chains synthesized in vitro are not glycosylated but do retain the NH2-terminal signal peptides (28, 29) . The largest band.in lane b probably corresponds to spot c in Fig. IA and (Fig. 2) . Furthermore, BFO.3 cells contain cytoplasmic granules or vesicles, which intensely fluoresce when fixed cells are stained with anti-a conjugated to rhodamine (7) . These granules or vesicles may sequester the precursor(s) for secreted IgA. A lack of glycosylation is probably not the explanation for why these a chains are not secreted, because tunicamycin does not inhibit the secretion of IgA from ID150 cells (data not shown). The half-life ofthe a chains in IDiS0 cells is less than 2 hr and therefore the turnover of as is much more rapid in ID150 than in BFO.3 cells (data not shown).
ID150 cells also contain mRNAs that can be translated in vitro to yield the polypeptide precursors for as and am (although they do have much more of the mRNA coding for as). However, biosynthetic labeling of ID150 for 6 hr failed to show any spot corresponding to am (Fig. 1B) . These results indicate that glycosylation is involved in the processing ofprecursor molecules for am and a,. It is unknown why fucose, which is believed to be a terminal sugar, is incorporated into the precursor molecule (spot a) as well as into the more acidic a chains, although Sidman (32) reported that fucose labled the intracellular precursor ofp. chain similarly to mannose.
Three a RNAs. Membrane-bound and secreted p. chains are encoded by two different mRNAs (2.7 and 2.4 kb), which differ in sequence at their 3' ends (4-6). BFO.3 cells contain approximately equal amounts of three RNAs that hybridize with the a probe, 1.7, 2.1, and 3.1 kb in length, whereas ID150 cells contain relatively much more of the 1.7-kb a RNA but do also contain the two larger RNAs. Only two a polypeptides appeared to be obtained by in vitro translation ofRNA from BFO.3 cells. It is possible that one of the larger a RNAs is not a functional mRNA 6r that the two larger a RNAs encode the same size polypeptide chain, or, perhaps, the identical polypeptide chain. It does not appear likely that one of the two larger a RNAs is an incompletely processed nuclear RNA that has leaked into the cytoplasmic fraction, because the amounts of these two larger RNAs are comparable to the amount of 1.7-kb RNA in BFO.3 cells. Furthermore, when a sequences present in total cell or nuclear RNAs from BFO.3 and ID150 cells were examined on RNA blots, the nuclear species larger than 3.1 kb were present in much lower amounts than were any of the three cytoplasmic a RNAs, and the amounts ofthe three cytoplasmic a RNAs relative to each other were the same as in the cytoplasm (data not shown).
Transcription of the a RNAs. Early et al (33) reported that the two different mRNAs for A. chains were transcribed from the same pu gene and were produced either by differential termination of transcription, or by alternative splicing of a single RNA transcript. It appears likely that the three a RNAs are also transcribed from one a gene, because Southern blots of genomic DNAs from BFO.3 and ID150 cells indicate that these cells contain one rearranged a gene with the identical restriction map in both cell lines (unpublished-data). Because the relative amounts ofthe three a RNAs differ between the lymphoma and hybridoma cells, mechanisms to regulate the termination of transcription or the preferential use ofcertain splice sites in the a RNA transcript(s) must exist.
